15:00 - 16:00
ET
Webcast
Treatment options for chronic myeloid leukemia (CML) and how to minimize side effects
Chronic myeloid leukemia (CML) is a rare type of leukemia that can happen when cells that make the blood develop a genetic change called BCR-ABL1 (Philadelphia chromone). Dr. M. Lynn Savoie, hematologist at Tom Baker Cancer Center, will discuss treatment options, including hematopoiesis stem cell transplants, and ways to minimize side effects of CML and its treatment.
Dr. M. Lynn Savoie
Clinical Associate Professor, Division of Hematology and Hematologic Malignancies, University of Calgary Calgary, AB
Dr. Lynn Savoie is a Clinical Associate Professor in the Departments of Medicine and Oncology at the University of Calgary as well as a member of the Department of Hematologic Malignancies and Bone Marrow Transplantation at the Tom Baker Cancer Centre in Calgary. She received her medical degree from Dalhousie University in Halifax where she also completed her internal medicine residency. Her hematology fellowship was completed at the University of Manitoba followed by a clinical Leukemia/Bone marrow transplantation fellowship with the Leukemia/BMT program of British Columbia.
Her interests lie in myeloid malignancies and medical education. She is the local primary investigator for a number of clinical trials including in CML, AML. MDS and ALL. She is the current secretary of the recently formed Canadian Leukemia Study Group and the co-chair of the leukemia subcommittee at the Canadian Cancer Trials Group. She is the previous chair of the hematology component of medical education at the University of Calgary as well as chair of the Hematology exam committee at the Royal College of Physicians and Surgeons.
Her interests lie in myeloid malignancies and medical education. She is the local primary investigator for a number of clinical trials including in CML, AML. MDS and ALL. She is the current secretary of the recently formed Canadian Leukemia Study Group and the co-chair of the leukemia subcommittee at the Canadian Cancer Trials Group. She is the previous chair of the hematology component of medical education at the University of Calgary as well as chair of the Hematology exam committee at the Royal College of Physicians and Surgeons.